# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-02-26)

**Core value:** Deliver a reproducible, scheduler-agnostic pipeline that can process thousands of public samples and produce statistically robust EBV copy number association results.
**Current focus:** Project closeout — all roadmap phases complete

## Current Position

Phase: 6 of 6 (Reporting & HPC Portability)
Plan: 3 of 3 in current phase
Status: Complete
Last activity: 2026-02-26 — Phase 6 Wave 3 completed (reproducibility checks + HPC portability docs)

Progress: [██████████] 100%

## Performance Metrics

**Velocity:**
- Total plans completed: 18
- Average duration: ~45 min
- Total execution time: ~13.5 hours

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| 1 | 3 | ~2.4h | ~48m |
| 2 | 3 | ~2.0h | ~40m |
| 3 | 3 | ~2.0h | ~40m |
| 4 | 3 | ~2.1h | ~42m |
| 5 | 3 | ~2.5h | ~50m |
| 6 | 3 | ~2.5h | ~50m |

**Recent Trend:**
- Last 5 plans: 05-02, 05-03, 06-01, 06-02, 06-03
- Trend: Complete

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- [Init]: Use Nextflow (nf-core style) for workflow orchestration.
- [Init]: Baseline statistical method is linear models with required covariates.
- [Init]: Prioritize scheduler-agnostic HPC deployment.
- [Phase5]: Enforce EBV gene presence in RNA ingest by default.
- [Phase5]: Support raw FASTQ RNA recount against combined host+EBV references.
- [Phase6]: Emit workflow-native reporting, dashboard, and reproducibility artifacts.

### Pending Todos

No pending roadmap tasks; optional future work includes method extensions and external dashboard hosting.

### Blockers/Concerns

No critical blockers; cluster-specific tuning still recommended per site policy.

## Session Continuity

Last session: 2026-02-26 16:xx
Stopped at: Full roadmap completion and closeout documentation
Resume file: .planning/COMPLETION-SUMMARY.md
